你即將離開本站

並前往https://www.prnewswire.com/news-releases/lillys-tirzepatide-achieves-all-primary-and-key-secondary-study-outcomes-against-insulin-glargine-in-adults-with-type-2-diabetes-and-increased-cardiovascular-risk-in-surpass-4-trial-301295524.html

Lilly's tirzepatide achieves all primary and key secondary ...

SURPASS -4 is the largest and longest trial of the program to date and is the fifth and final global registration study for tirzepatide in ...

確定！ 回上一頁

查詢 「SURPASS-4」的人也找了：

  1. -SURPASS 4 pdf
    2.
  2. surpass 4答案
    3.
  3. SURPASS 4 Answer
    4.
  4. SURPASS Student Book 1
    5.
  5. -SURPASS Student Book 4
    6.
  6. Surpass GO Beyond Expectations 4
    7.
  7. Surpass Student Book 1 pdf
    8.
  8. SURPASS 3 Answer
    9.